HOME >> BIOLOGY >> NEWS
Experts to share biotech future world

ROCKVILLE, Md. --A child born in 2010 should benefit from better health and disease diagnosis, improved foods, more efficient clean up of toxin spills, and a more "realistic" view of evolution, thanks to the current revolution in applying biotechnology to the flood of new gene sequencing data. Leading experts will discuss what's in store for the 2010 genomic generation at a special symposium, "Advancing the Frontiers of Biotechnology" at the University System of Maryland's Shady Grove Campus (directions below), 8:30 a.m., November 9.

The free symposium will be held in honor of the inauguration of Jennie Hunter-Cevera, Ph.D., as the second president of the University of Maryland Biotechnology Institute (UMBI) on November 10, also at USM, Shady Grove.

"It is indeed an honor for UMBI to host such a distinguished group of speakers (list below) in the heart of Maryland's "Genomic Junction" who will discuss the future of biotechnology," says Hunter-Cevera. She was most recently head of the Center for Environmental Biotechnology and director of the Department of Environmental Biology and Biochemistry for the Lawrence Berkeley National Laboratory, University of California.

At the inaugural symposium, experts will discuss likely changes for the post-2010 "genomics" generation, including:

  • Preventing Infections: Analysis of all the genes of both humans and human disease-causing microorganisms will give drug designers pinpoint accuracy to treat infectious diseases from influenza to AIDS on a patient-to-patient basis.
  • Monitoring Cancer Treatments: Tissue microarray technology, so far replacing microscope slide tests in 100 laboratories in the world, will help clinicians get 9,000 different analyses of 1,000 tissue samples at once for a rapid diagnosis of cancer type, progression, and patient risk factors.
  • Green Manufacturing: Computer analysis of microbial enzyme genes will help manufacturers, e.g. paper mills, to limit use of sulfur and other p
    '"/>


Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
2-Nov-2000


Page: 1 2 3

Related biology news :

1. Experts to lecture in US cities this spring about new human origins research
2. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans
3. Experts deliver foot and mouth disease warning
4. Experts offer the skinny on search for healthy fat
5. Experts discuss recommendations of NY state task force on genetic testing
6. Expanded Global Change Experts Directory available
7. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
8. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
9. Experts say independent scientific panels useful in advising judges in complex cases
10. Experts say diet and exercise play critical role in cancer prevention
11. Experts to study informed consent in national gene transfer research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experts share biotech future world

(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... 2015 CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announced ... has approved the Company,s application to conduct a Phase ... (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... CARDIFF, UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, ... energy projects in Europe and the United States and ... programme highlights planned for SPIE Optics + Optoelectronics ... will feature over 700 technical presentations in 17 conferences ... international society for optics and photonics , the event ...
(Date:3/30/2015)... MADISON, Wis. , March 30, 2015  FUJIFILM ... ("Fujifilm") and Cellular Dynamics International, Inc. (CEO: Robert ... leading developer and manufacturer of fully functioning human cells ... the two companies have entered into a definitive agreement ... offer to be followed by a second step merger. ...
(Date:3/29/2015)... March 29, 2015 As a symbol ... required by our pharmaceutical manufacturing clients, Whitehouse Laboratories is ... of the Berkenstock Race Team for the 2015 race ... only speed, but a strong sense of precision and ... lead to success in the quality control testing laboratory. ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2
Cached News: